PERANAN GEN CD40 DAN CD40L (CD154) DALAM PENINGKATAN EKSPRESI SEL TIROID
Abstract
CD40 is a member of TNFR which is generally expressed on the surface of B cells. Its activity is influenced by CD40L (CD154) in activated CD4 + T cells. CD40-CD154 interactions play a role in immune regulation, especially mediating the response of T cell-influenced B cells. Abnormal CD40-CD154 interactions can result in GD, by affecting thyroid cell activity. CD40 gene polymorphism has been reported to improve the translation process and expression of CD40 proteins that influence the pathogenesis of GD.
Keywords: CD40, CD154, polymorphism, thyroid
Full Text:
PDFReferences
Abbas, Abul K, Andrew H. Lichtman, S. P. (2010). Cellular and Molecular Immunology (6th ed.). China: Saunders-Elsevier Inc.
Anna L. Peters, Laura L. Stunz, and G. A. B. (2009). CD40 and Autoimmunity: The Dark Side of a Great Activator. Seminars in Immunology, 21(5), 293–300. https://doi.org/10.1016/j.smim.2009.05.012
Chatterjee S, P. J. (2009). Role of 5’- and 3’-Untranslated Regions of mRNAs in Human Diseases. Biol. Cell, 101(5), 251–262. https://doi.org/10.1042/BC20080104.
Galofr, J. C., & e, Leonidas H. Duntas, L. D. Premawardhana, and T. F. D. (2012). Advances in Graves’ Disease. Journal of Thyroid Research, 2012, 2. https://doi.org/10.1155/2010/809231
GarcÃa-Bermúdez, M., González-Juanatey, C., López-MejÃas, R., Teruel, M., Corrales, A., Miranda-Filloy, J. A., González-Gay, M. A. (2012). Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients. PLOS ONE, 7(11), e49214.
Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, T. K. (2000). Polimerase Chain Reaction with Confronting Two-Pair Primers for Polymorphism Genotip. Jpn J Cancer Res., 91(9), 865–868. https://doi.org/10.1111/j.1349-7006.2000.tb01026.x
Houston, F. A., Wilson, V., Jennings, C. E., Owen, C. J., Donaldson, P., Perros, P., & and Simon H.S. Pearce. (2004). Role of the CD40 Locus in Graves’ Disease. Thyroid, 14(7), 506–509. https://doi.org/10.1089/1050725041517039
Huber AK, Finkelman FD, Li CW, Concepcion E, Smith E, Jacobson E, Latif R, Keddache M, Zhang W, T. Y. (2012). Genetically-Driven Target Tissue Over-Expression of CD40: A Novel Mechanism in Autoimmune Disease. J Immunol, 186(6), 3043–3053.
Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, T. Y. (2007). A CD40 Kozak Sequence Polymorphism and Susceptibility to Antibody-Mediated Autoimmune Condition: The Role of CD40 Tissue-Spesific Expression. Genes and Immunity, 8(3), 205–214. https://doi.org/10.1038/sj.gene.6364375
Junichi Tani and Yuji Hiromatsu. (2013). Genetic Susceptibility to Graves’ Ophthalmopaty. https://doi.org/10.5772/53441
Kumar Ashok, S. S. dan S. B. (2010). Common Medical Disorders In Obstetrics. India: Jaypee-Brothers Medical Publisher.
Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, Zebracka J, Steinhof-Radwanska K, Hasse-Lazar K, Hiromatsu Y, Jarzab B, B. T. (2005). Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves’ disease. Thyroid, 15(10), 1119–1124. https://doi.org/10.1089/thy.2005.15.1119
Ming Li, Haiming Sun, Shoujun Liu, Jun Yu, Qiang Li, Peng Liu, Hongmei Shen, D. S. (2012). CD40 C/T-1 polymorphism plays different roles in Graves’ disease and Hashimoto’s thyroiditis: a meta-analysis. Endocrine Journal, 59(12), 1041–1050. https://doi.org/https://doi.org/10.1507/endocrj.EJ12-0126
Mohammad Hossein Karimi, and A. A. P. (2012). CD40 and Tolerance Induction. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY, 11(1), 1–13.
Myśliwiec J, Waligórski D, Nikołajuk A, G. M. (2007). Soluble CD40 and its ligand CD154 in patients with Graves’ ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy. Advance in Medical Science, 52, 104–108.
NCBI. Homo sapiens CD40 ligand (CD40LG), RefSeqGene (LRG_141) on chromosome X. Retrieved February 1, 2015, from http://www.ncbi.nlm.nih.gov/nuccore/NG_007280.1?from= 5001&to=17214&report=genbank
NCBI. Homo sapiens CD40 molecule, TNF receptor superfamily member 5 (CD40). Retrieved December 13, 2014, from http://www.ncbi.nlm.nih.gov/nuccore/163965404?report=fasta&from=5001&to=16479
Sapna Chadha, Katie Miller, Lisa Farwell, Liz B Lightstone, Mark J Daly, J. D. R. & T. J. V. (2005). Haplotype Structure of TNFRSF5-TNFSF5 (CD40–CD40L) and Association Analysis in Systemic Lupus Erythematosus. European Journal of Human Genetics, 13, 669–676.
Tomer, Y., Concepcion, E., & and David A. Greenberg. (2002). A C/T Single-Nucleotide Polymorphism in the Region of the CD40 Gene is Associated with Graves’ Disease. Thyroid, 12 (12).
Tomer Y, D. T. (2003). Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function. Endocrine Reviews, 24(5), 694–717. https://doi.org/10.1210/er.2002-0030
Van Kooten C, B. J. (1996). CD40-CD40 ligand: a multifunctional receptor-ligand pair. Advance in Immunologis, 61, 1–77.
Van Kooten C, B. J. (2000). CD40-CD40 Ligand. Journal of Leukocyte Biology., 67.
Yoshihiro Onouchi, Sakura Onoue, Mayumi Tamari, Keiko Wakui, Yoshimitsu Fukushima, Mayumi Yashiro, Yoshikazu Nakamura, Hiroshi Yanagawa, Fumio Kishi, Kazunobu Ouchi, Masaru Terai, Kunihiro Hamamoto, Fumiyo Kudo, Hiroyuki Aotsuka, Yoshitake Sato, Akiyoshi , Y. N. & A. H. (2004). CD40 Ligand Gene and Kawasaki Disease. European Journal of Human Genetics, 12, 1062–1068.
Refbacks
- There are currently no refbacks.
Lembaga Penerbitan Universitas Esa Unggul
Jalan Arjuna Utara No 9 Kebon Jeruk Jakarta 11510
Telp : 021 5674223 ext 266
email : [email protected]